Skip to main content
. 2018 Oct 8;7(12):R294–R303. doi: 10.1530/EC-18-0283

Figure 2.

Figure 2

Dose–response relationships between 25(OH)D and risk estimates of all-cause mortality and prostate cancer-specific mortality. (A) Risk estimates with 95% CI for the association between 25(OH)D and all-cause mortality. (B) Risk estimates with 95% CI for the association between 25(OH)D and prostate cancer-specific mortality.